Robert, E, Guibaud, P.
Maternal valproic acid and congenital neural tube defects. Lancet
1982; 2: 937.
Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. Reprod Toxicol
2006; 22: 214–26.
Tomson, T, Battino, D.
Teratogenic effects of antiepileptic medications. Neurol Clin
2009; 27: 993–1002.
Vajda, FJ, O'Brien, TJ, Hitchcock, A, Graham, J, Cook, M, Lander, C, et al. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci
2004; 11: 854–8.
Bromley, RL, Baker, GA, Meador, KJ. Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero. Curr Opin Neurol
2009; 22: 162–6.
Meador, KJ, Baker, GA, Browning, N, Clayton-Smith, J, Combs-Cantrell, DT, Cohen, M, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med
2009; 360: 1597–605.
Adab, N, Kini, U, Vinten, J, Ayres, J, Baker, G, Clayton-Smith, J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry
2004; 75: 1575–83.
Lagrange, AH. Folic acid supplementation for women with epilepsy who might become pregnant. Nat Clin Pract Neurol
2009; 5: 16–7.
Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
2009; 28: 1–10.
Wolff, T, Witkop, CT, Miller, T, Syed, SB. Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med
2009; 150: 632–9.
Daly, LE, Kirke, PN, Molloy, A, Weir, DG, Scott, JM. Folate levels and neural tube defects. Implications for prevention. JAMA
1995; 274: 1698–702.
Lumley, J, Watson, L, Watson, M, Bower, C.
Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev
2001; 3: CD001056.
Evidence-based guidelines for treating bipolar disorder: revised second edition – recommendations from the British Association for Psychopharmacology. J Psychopharmacol
2009; 23: 346–88.
Taylor, D, Paton, C, Kapur, S.
The Maudsley Prescribing Guidelines, 10th edn. Informa Healthcare, 2009.
James, L, Barnes, TRE, Lelliott, P, Paton, C.
Informing patients of the teratogenic potential of mood stabilising drugs; a case notes review of the practice of psychiatrists. J Psychopharmacol
2007; 21: 815–9.
Wobrock, T, Weinmann, S, Falkai, P, Gaebel, W.
Quality assurance in psychiatry: quality indicators and guideline implementation. Eur Arch Psychiatry Clin Neurosci
2009; 259 (suppl 2): S219–26.
Mace, S, Taylor, D.
A prescription survey of antipsychotic use in England and Wales following the introduction of NICE guidance. Int J Psychiatry Clin Pract
2005; 9: 124–9.
Ozbilen, M, Cottrell, D.
Compliance with NICE guidance: concurrent use of different antipsychotic drugs. Clin Governance: Int J
2007; 12: 118–21.
Paton, C, Barnes, TRE, Cavanagh, MR, Taylor, D, Lelliott, P.
High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing. Br J Psychiatry
2008; 192: 435–9.
Robertson, J, Polifka, JE, Avner, M, Chambers, C, Delevan, G, Koren, G, et al. A survey of pregnant women using isotretinoin. Birth Defects Res A Clin Mol Teratol
2005; 73: 881–7.
Barnes, TR, Paton, C, Hancock, E, Cavanagh, MR, Taylor, D, Lelliott, P.
Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme. Acta Psychiatr Scand
2008; 118: 26–33.
Prescribing Observatory for Mental Health. Prescribing of High-Dose and Combination Antipsychotics on Adult Acute and Intensive Care Wards: Supplementary Audit (March 2009). Royal College of Psychiatrists, 2009.
Duncan, S, Mercho, S, Lopes-Cendes, I, Seni, MH, Benjamin, A, Dubeau, F, et al. Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality. Epilepsia
2001; 42: 750–3.
Czeizel, AE, Vargha, P.
Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am J Obstet Gynecol
2004; 191: 790–4.
Vollset, SE, Gjessing, HK, Tandberg, A, Ronning, T, Irgens, LM, Baste, V, et al. Folate supplementation and twin pregnancies. Epidemiology
2005; 16: 201–5.